Author:
Koscielny J.,Jámbor C.,Weber C. F.,Hellstern P.,von Heymann C.,Greinacher A.,Kopp H.-G.,Möhle R.,Kanz L.
Publisher
Springer Berlin Heidelberg
Reference42 articles.
1. Balduini CL, Noris P, Belletti S, Spedini P, Gamba G (1999) In vitro and in vivo effects of desmopressin on platelet function. Haematologica 84: 891–896
2. Burroughs AK, Matthews K, Qadiri M, Thomas N, Kernoff P, Tuddenham E, McIntyre N (1985) Desmopressin and bleeding time in patients with cirrhosis. Br Med J (Clin Res Ed) 291(6506): 1377–81
3. Budde U, Schaefer G, Mueller N, Egli H, Dent J, Ruggeri Z, Zimmerman T (1984) Acquired von Willebrand’s disease in the myeloproliferative syndrome. Blood 64(5): 981–5
4. Carless PA, Henry DA, Moxey AJ, O’Connell D, McClelland B, Henderson KM, Sly K, Laupacis A, Fergusson D (2006) Desmopressin for minimizing perioperative allogeneic blood transfusion (Review). Cochrane Library, Issue 3 1–40
5. De La Fuente B et al. (1985) Response of patients with mild and moderate hemophilia Aand von Willebrand disease to treatment with desmopressin. Ann Int Med 103: 6–14